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In recent years, there has been a renewed interest in the use of herbal medicines. Quality 
control and safety are two critical principles to be considered in the production process of 
herbal medicines. This review study aimed to investigate the condition of the countries other 
than Iran in terms of observing the safety principles, quality control, and meeting the standard 
of herbal drug use.  In this systematic review, references were selected using the search terms 
“health-care quality” and “challenges of herbal medicine usage” from the databases “Web of 
Science” and “PubMed” published between 2000 and 2019. To select the resources among the 
selected literature, confirmation was accomplished by two researchers and Cohen’s kappa 
coefficient (κ). The selected papers were classified based on publication year, journal, country, 
reference standards, regulation, toxicity evaluation, quality control, efficacy, safety, and 
adverse effects in herbal medicine. From 1532 retrieved papers, 27 papers with an estimated 
Cohen’s kappa coefficient of 0.81 were confirmed and included in the study. Based on the 
analysis, the main findings of the papers were thematically classified into seven subcategories 
as follows: reference standards in herbal medicine, regulation of herbal medicinal products, 
toxicity evaluation for herbal products, quality control of herbal medicine, efficacy, adverse 
effects of herbal medicine, and safety. Given the significance of the effects of herbal medicines 
on health care quality, it is essential to codify guidelines on the proper use of these drugs.
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Introduction 
Herbal medicines are currently considered the oldest 
and most commonly used medical system worldwide (1). 
A large proportion of the population in developing and 
developed countries tend to rely on the herbal medicines 
for their primary healthcare. Based on the evidence, 
more than 90% of people in Africa, 70% in India, 70% 
in Germany, 48% in Australia, 70% in Canada, 42% in 
America, 39% in Belgium, and 76% in France meet their 
healthcare needs by using herbal medicines (2-6).
Herbal medicines are of high economic value. In the 
United States, it takes an average of 12 years for a new 
synthetic drug from the research on and discovery of a 
new synthetic drug to market with a minimum cost of 
$230 million. By comparison, the study and identification 
of herbal medicines require less time and cost (3). Based 
on estimations, the global herbal medicines market 
enjoyed an annual growth rate of over 15% (7) and the 
global trade of herbal products is expected to reach $70 
million in the United States by 2050 (3). 
As per the statistical reports, there has been a 31.7% 
increase in the volume of China’s e-commerce market of 
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herbal medicines in 2012 (8). The use of herbal medicines 
takes root to the traditional knowledge or the observation, 
and real experiences gained during the time. Plant-derived 
herbs interact with human biology (9); hence, quality 
control, safety insurance, proper usage, observance of 
reference standards, and efficacy are among the valuable 
components of herbal drug consumption (10).
In Germany, the usage of herbal medicines is regulated 
by the Healthcare & Medical Organization. To ensure 
the herbal drugs’ quality, safety, and effects, they are 
required to be produced in an environment known as 
good manufacturing practice (GMP). Until now, almost 
380 papers on 360 plant species have been published to 
address this approach. In Canada, this approach has been 
supported by the preparation of a draft entitled “Guideline 
on the Quality of Herbal Medicinal Products” by the 
Committee on Herbal Medicinal Products (HMPC). This 
guideline lists the qualitative requirements for preparation 
of the herbal medicines in Canada and elucidates the 
required attributes, diagnosis and competency of the 
reference standards (11). 
Despite the ever-increasing global acceptance of herbal 
medicine, cultivation of medicinal plants faces certain 
challenges. In other words, the industrial infrastructure of 
herbal medicines has not been given due consideration. 
Quality control and medicinal monitoring for the 
medicine’s toxicity is poor. There is no monitoring of the 
herbal medicines’ side effects and international standard 
describing the method and dosage of herbal medicines. 
Also, the people’s knowledge about the complications 
of self-medication and the potential interactions of 
herbal medicines with chemical drugs is inadequate, 
and the proper and timely usage of the herbal medicines 
has not been given due attention. All these are among 
the challenges that may influence the effects of herbal 
medicines on health care (4).
In many European Union nations, herbal drugs are not 
covered by the health insurance; hence, many of these 
nations do not have any incentive to make investment 
or conduct clinical and non-clinical research in this field 
(12).
International Union of Practical and Abstract Chemistry 
(IUPAC) has issued some protocols on the quality, safety, 
control, efficiency, standardization, and documentation 
of herbal medicines. These protocols illuminate the 
important aspects of the chemical analysis of the herbs. 
If IUPAC fully implements these procedures, the World 
Health Organization (WHO) will start seeking out 
herbal medicines by adopting a new approach and would 
advance WHO Traditional Medicine Strategy 2014–2023 
for the promotion of the complementary medicine and 
international industry of the herbal drugs production 
(13). 
Iran is known as one of the oldest and richest nations in 
the field of herbal medicine. Due to the high acceptance of 
herbal medicines by the Iranians, the Ministry of Health 
and Medical Education has committed itself to promote 
the usage rate of these types of medicines in health care 
(14). 
Over 80% of the popular and usable medicinal herbs 
are planted in Iran. Although herbal medicinal products 
play a significant role in Iran’s economy as a significant 
component of its non-oil products exports, its RSCA 
index estimated by the Food & Agriculture Organization 
in 1995-2008 was reported to be 0.93-0.83. Hence, Iran 
has shown a decreasing trend in comparison to the other 
six leading exporting nations of these products (15). The 
familiarity of all levels of health care providers with the 
herbal medicine capabilities is vital since it can assist 
health economics and promote the health care quality, 
provided that effective solutions can be developed for its 
potential challenges. This review study aimed to invest 
other countries’ condition in terms of observing the safety 
principles, quality control, and meeting the standard of 
herbal drug use. 
Materials and Methods 
Study of the effects of herbal medicines consumption on 
health care quality and the related challenges across the 
world
This systematic review was done in accordance with 
the consistent guidelines of Preferred Reporting Items 
for Systematic Reviews (PRISMA) statement suggested 
by Moher et al (16). More clearly, we focused on well-
formulated research questions to better understand the 
effects of herbal medicine use on healthcare quality. 
PRISMA methodology was implemented by the following 
five main steps: literature search, inclusion and exclusion 
criteria, study selection, quality assessment, and data 
extraction and synthesis.
Literature search
To identify the papers eligible for the study’s purpose, 
a comprehensive search was done in the electronic 
databases of PubMed and Web of Science between 2000 
and 2019. These databases provide a rich source of 
valuable and reliable information about the impact of 
herbal medicine on healthcare quality in different areas. 
In this step, references were selected using the search 
terms “herbal medicine”, “herbal drug”, “medicinal plants”, 
“effectiveness”, “safety”, “evaluation”, “quality”, “adverse 
effects”, “efficacy”, and “reference standard”. A total of 
1532 academic papers were identified. EndNote software 
was used to identify and delete the duplicate papers, and 
797 papers remained for further analysis (Figure 1).
Inclusion and exclusion criteria
The original research papers with accessible full text 
in English and appearing in academic journals and 
international conferences were deemed as eligible for 
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inclusion in the present study. The following research 
types were excluded from the study: reports, brief 
reports, reviews, editorial letters, case reports, case 
studies, perspective articles, symposiums, posters, brief 
communications, and commentaries, on-English papers, 
papers with only accessible abstract, and papers unrelated 
to the topic of the research or containing insufficient and 
vague information.
Study selection
The selection of the papers was carried out in two steps. 
First, two of the authors screened the papers independently 
in terms of titles and abstracts by considering the inclusion 
and exclusion criteria. In this way, all the irrelevant studies 
were deleted, and a total number of 280 potentially relevant 
papers remained. Secondly, to determine the eligibility of 
the selected papers, the authors independently reviewed 
the full texts of the papers selected in the previous stage. 
Finally, to reach a consensus, a careful step was taken to 
select the eligible papers. The foregoing steps resulted in 
the collection of 27 academic papers addressing the effects 
of herbal medicine on healthcare quality, their usage rates, 
and also challenges facing their usage (Figure 1).
Quality assessment
In this stage, the assessment of the quality of the selected 
studies was done by using the Mixed Methods Appraisal 
Tool (MMAT) proposed by Pluye et al (16-18). To this end, 
two authors carefully studied the papers independently. 
In case of the agreement of two authors, the paper was 
selected and in case of lack of agreement, a third author 
was asked to judge. Furthermore, the rate of agreement 
between two authors regarding the confirmation of the 
selected papers was measured by the SPSS using the 
Cohen’s kappa coefficient. 
Data extraction and synthesis
In this step, an initial data extraction form was developed 
to draw the data elements from each paper. The collected 
data were then organized based on two sub-categories 
including general items (author, publication year, country/
state, study purpose, results, and findings) and specific 
items (reference standards in herbal medicine, regulation 
of herbal medicinal products, toxicity evaluation for 
herbal products, quality control of herbal medicine, 
efficacy, adverse effects of herbal medicine, and safety of 
herbal medicines) (Table 1).
Data were extracted by two review authors from 
each article independently. As mentioned above, any 
disagreement was handled by consensus between the two 
authors or the mediation of the third author, if necessary. 
In the next step, a thematic analysis was done to combine 
similar findings (19,20). Furthermore, the extracted 
























Records identified through database searching 
(N=1532) 
Number of papers in databases: 
• Science Direct: N= 664 
• PubMed: N=83 










Full-text articles were assessed for 
eligibility 




Records were excluded 
























































Total included studies 




Records that were not 
related removed 
(N= 253) 
Figure 1. Flow diagram of our review process.
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Table 1. Summary of the selected articles’ results based on herbal medicine
Country  Study purpose Results and finding Reference
USA
A tool for rapid identification 
of potential herbal medicine-
drug interactions 2011 update: 
a review 
•	 2148 references on the herbal medicines interactions published during 2007-2010 
were reviewed 
•	 The herbal medicines interactions network allows the clinical practitioners to keep 
themselves updated about the possible herbal medicines adverse effects based on the 
latest information 
(36)
Malaysia Herbal medicine knowledge base system
•	 Herbal medicines knowledge platform includes four main categories of knowledge 
that are as follows: knowledge about the plants, knowledge about the traditional 
medicine, knowledge about processing and knowledge about pharmacology
•	 Many medicines presently available for treatment of disease have some weaknesses 
including low efficacy due to drug-resistance, high toxicity or high cost. Such concerns, 
consequently, have driven the commercial drug companies toward the research and 
development of new plant-driven drugs. The herbal drugs platform would assist the 
pharmaceutical companies in the discovery of herbal medicines
(37)
Taiwan
An automated technique 




As many as 1920 herbal medicines were studied. Medication errors including improper 
prescription of the herbal medicines may cause serious adverse effects for the patients. 
Applying an automatic method for identifying the potential improper prescription of the 
herbal medicines with a sensitivity of 97.1% is assumed to be a successful model for the 
automatic diagnosis of improper drug orders 
(38)
Brazil Regulation of herbal 
medicines in Brazil
Based on a cross-sectional study on 364 pregnant women in teaching hospital of Gondar 
in the northeast Ethiopia in 2016, 48.6% have used herbal medicines during their 
pregnancy while the majority of the herbal drug consumers (89.8%) have not consulted 
with their physician regarding the consumption of the herbal medicines 
(39)
Germany
Herbal Reference Standards: 
applications, definitions and 
regulatory requirements
Herbal medicines regulations imposed by Brazil have forbidden the manufacturing, sale 
or supply/distribution of the herbal products (even the export products) prior to their 
formal registration. The herbal medicine registration is valid for 5 years and is subject to 
re-record every five years 
(14)
Brazil
Herbal medicines: old and 
new concepts, truths and 
misunderstandings
The herbal healing products and food and dietary supplements must comply with the 
legal requirements on the production, test, storage and distribution. Compilation of 
reference standards for specifying the herbal medicines with complex combination is a 
common challenge that needs to be effectively addressed 
(24)
Japan
Regulation of traditional 
herbal medicinal products in 
Japan
Based on a new survey on about 1000 herbal medicines, only 156 drugs were clinically 
tested usable for pharmacological and treatment purposes. It is noteworthy that efficacy 
of 1/3 of the 156 drugs was not certified in the clinical tests
(31)
India
Quality Related safety issue-
evidence-based validation 
of herbal medicine farm to 
pharma
•	 Japan’s medicine guideline is known as the governing legal reference for ensuring the 
quality of the herbal medicines in this country.
•	  Data requirements for the application of herbal healing products in Japan include the 




The use of community 
herbal monographs to 
facilitate registrations and 
authorizations of herbal 
medicinal products in the 
European Union 2004–2012
Major challenges to the development and promotion of the herbal medicines are as 




Essence of Chinese herbal 
medicines
By 2013, the number of traditional herbal products formally registered in the UN 
members with monographs on the herbal products consumption was 1015 compound 
products. In herbal compounds, mostly 2 to 3 drugs or herbal plants are used. EDQM 
supervises the quality standards in the monographs of the European drug guideline
(27)
Germany
Future visions for traditional 
and herbal medicinal 
Products—A global practice 
for evaluation and regulation?
Network pharmacological attitudes toward herbal medicines is a new research paradigm 
useful for transforming the experience-based medicine to evidence based medicine 




Systems pharmacology in drug 
discovery and therapeutic 
insight for herbal medicines
There is a shared attitude on the major elements of the supervisory systems on the herbal 
products. Principally, the safety, efficacy, quality, risk management and product evaluation 
on a scientific basis must be taken into account. In addition, there is consensus among 
the practitioners that the patients should be provided with proper information about the 
traditional and medical products
(30)
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Country  Study purpose Results and finding Reference
 China
Community pharmacist’s 
responsibilities with regards 
to traditional medicine/
complementary medicine 
products: A systematic 
literature review
A systemic pharmacological platform for the herbal medicines allows the analysis of the 
herbs effective on the treatment of a given disease while the chemical data platform 
would assist research on the active ingredients of the available plants. Such platform may 




Safety Surveillance of 
traditional Chinese medicine: 
current and future
This study examined the responsibilities of the pharmacists in the safety and proper use 
of herbal medicines that are as follows: confirming and certifying the herbal medicinal 
products, having knowledge about the herbal medicines, ensuring the safe consumption, 
documenting the herbal medicines use, reporting the adverse effects of the herbal drugs, 
providing training and cooperating with other health care practitioners.
(42)
Malaysia Pharmacovigilance of herbal medicines: Current state and 
future directions
Herbal medicines are commonly consumed together with other medicines. Accordingly, 
it is necessary to monitor the possible consequences of such combined usage and control 
any undesirable adverse 
(32)
India
Challenges and opportunities 
in the advancement of herbal 
medicine: India’s position and 
role in a global context
Lack of ecological variety, excessive exploitation, biological unlawful reproduction, non-
scientific usage of the herbal drugs, industrialization and lack of regulation and framework 




Context effects in western 
herbal medicine: fundamental 
to effectiveness?
Based on the qualitative studies on the herbal medicines, the patient-specialist 
interaction, treatment environment and background effects of the herbs are among the 
factors affecting the efficacy of the herbal medicines 
(43)
Sweden Requirements on efficacy of herbal medicinal products
Documentation of the usage technique of herbal medicines positively affects herbal 
medicines safety evaluation and quality control (28)
Australia Changing the knowledge base in Western herbal medicine 
The efficacy of the herbal medicines in treating specific diseases, the association between 
the herbal combinations and medical actions and the interactions between the medicinal 
products and medicinal herbs are among the factors influencing the health care quality in 
the herbal medicine 
(44)
Canada Regulation of natural health products in Canada
In this study, the actions taken by the WHO regarding identifying the herbal medicines, 
certifying the products certificate and imposing the agriculture-related policies were 
mainly examined
(45)
EU Quality standards of the European Pharmacopoeia
12% of the European encyclopedia has been devoted to the herbal medicines including 
the scientific names of the plants (species, sub-species and type), manner and 
consumption dose
(9)
Germany Challenges of safety evaluation •	 Quality control is another key factor affecting the efficacy of the herbal plants (31)
Australia
Quality assessment of medical 
herbs and their extracts: 
Criteria and prerequisites for 
consistent safety and efficacy 
of herbal medicines
•	 The main requirements for evaluating the safety of herbal medicines have been 
illustrated in the EC/83/2001. 
•	 The medicinal herbs quality is an applied concept that is defined based on 




evaluation and scheduling of 
Chinese herbal medicines
Excessive usage of herbal medicines may result in reverse reactions, toxicity and/or death (23)
USA
Traditional knowledge of 
Western herbal medicine and 
complex systems science
Herbal medicine is based on the traditional knowledge or the common sense obtained 
during the time through observation and real experiences (46)
India 
Revival, modernization 
and integration of Indian 
traditional herbal medicine in 
clinical practice: importance, 
challenges and future 
Lack of compiled and well-organized rules and instructions for controlling the medicinal 
herbs, excessive harvest, weak agriculture techniques, weak actions before and after 
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description of the extracted themes was presented in the 
results. In addition, the validity of the themes extraction 
process was confirmed by cross-checking the papers and 
discussion between the two authors (21). The last step of 
methodology was summarizing the selected papers and 
identifying the major factors. This step was completed by 
calculating the frequencies and percentages for the items’ 
results. 
Results
Following the methodology steps, 1532 papers were 
retrieved from which 27 academic papers were included 
in the final analysis (Figure 1). Then, all articles were 
summarized so as to classify them in terms of the study 
characteristics, including publication year (Figure 2) and 
country (Figure 3). Afterward, based on the analysis, the 
main findings of papers were thematically classified into 
seven subcategories as follows: reference standards in 
herbal medicine, regulation of herbal medicinal products, 
toxicity evaluation for herbal products, quality control 
of herbal medicine, efficacy, adverse effects of herbal 
medicine and safety (Table 2).
Overview of study characteristics 
Distribution of papers by publication year 
The distribution of academic papers by publication year 
regarding the impact of herbal medicines on healthcare 
quality and challenges is illustrated in Figure 2.
The selected articles were published during the period 
2008-2017. The highest frequency (n: 8) of the papers 
addressing the effects of consumption of herbal medicinal 
products were published in 2014.
Distribution of selected articles based on the journal 
indicated that Journal of Ethnopharmacology published 9 
(33.37%, highest frequency) of the papers published on 
the effects of consumption of herbal medicinal products.
Distribution of papers by country 
The distribution of research papers on herbal medicines 
by country is illustrated in Figure 3. As illustrated, the 
following countries researched on the effects of herbal 
medicines on healthcare quality: USA, Malaysia, Taiwan, 
Ethiopia, Brazil, Germany, Japan, India, China, Canada, 
and the European Union (EU). The majority (11%) of 
studies have been published in China, India and Australia 
(Figure 3).
Distribution of papers by the extracted themes 
As per the results, from 27 papers in question, 3 (11.11%) 
and 8 (30%) papers cited the reference standards in herbal 
medicine and regulation of herbal medicinal products, 
respectively. Furthermore, 7 (26%) papers made reference 
to toxicity evaluation in herbal products, 11 (40.75%) 
to quality control of herbal medicine, 9 (33.33%) to the 
efficacy of herbal medicine, 7 (26%) to the adverse effects 
of herbal medicine, and 12 (44.45%) to the safety of herbal 
medicine (Table 2). 
Discussion
In recent years, many people use herbal medicinal 
products for health care promotion and therapeutic 
purposes either alone or combined with other drugs. Sen 
et al have argued that more than 60% of currently available 
anti-cancer drugs are derived from herbal products (4). 
According to the WHO report, 80% of the people in the 
advanced countries meet their medical needs by herbal 
medicines. Economic, political, and social changes in the 
world have made the medical application of these natural 
sources/products possible for those who do not have 
access to the currently available varied treatment methods 
(22,23). 
Accordingly, it is essential to pay due attention in 
all countries to the effects of herbal medicines on the 
healthcare quality and identifying the involved factors. 
In the findings obtained from this research, seven major 
factors effective on the herbal medicines and their effects 
on the healthcare quality were examined. To confirm 
the quality and attributes of a newly manufactured 
compounds, some formal legal requirements must be 














Figure 2. Distribution of articles frequency by publication year.
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substances incorporated in the European Medicine Manual 
published (EDQM), the primary reference standards refer 
to the appropriate standards for a given objective without 
any need to be compared with another standard currently 
in use for proving its appropriateness. Within the quality 
control framework, applying appropriate reference 
standards is assumed necessary to ensure the safety and 
efficacy of the products (24). According to the findings of 
this review, codification of a reference standard for each 
herbal medicine can provide convincing evidence on the 
quality control and non-toxicity of the medicine. In some 
nations such as China, a medicinal encyclopedia has been 
compiled to categorize the medicines based on toxicity 
index as follows: high toxic, toxic and non-toxic. Since July 
2012, new reports on the toxicology of herbal medicines 
have been presented in Australia under the supervision 
of the traditional medicine physicians. Although some 
herbal medicines have been approved based on the 
standard requirements, there is no such standard for some 
others due to lack of sufficient research (23). During the 
2010-2012 periods, as many as 81 new formulas have been 
added to the formal confirmatory standards in Japan. In 
2013, the updated edition of the manual of the standards 
containing the certificates of the herbal products and 
medicines was published (25). In accordance with the 
interview results, as with many other developing countries, 
Iran suffers from the scarcity of such standards. Given 
people’s lack of knowledge about the toxicity of herbal 
medicines, it is necessary to determine the toxicity of the 
drugs in the drug’s monographs. Training the distributors 
of the medicinal herbs should also be taken under the 
supervision of the Food and Drug Administration. 
 In the EU, a sophisticated supervisory framework on 
herbal medicine products has been incorporated in the 
revised guideline European commission (EC/83/2001) 
and (EC/63/2003). Based on this guideline, all the herbal 
medicines are required to comply with the GMP (11). This 
guideline gives some useful insight into what information 
should be incorporated in the order of herbal medicine 
as well as its medical function (26-28). To observe 
the quality control standards in the herbal medicine 
monographs, the least information including the scientific 
full name of the herb, content and ingredients mentioned 
in the prescription order as well as the identity number 
of the herb must be included to be submitted to the 
pharmacy (9, 29). To promote the legal framework for 
the registration of the herbal medicines, Brazil’s National 
Health Surveillance Agency (ANVISA) has certified the 
applied standard Resolution Directorate Collegiate (RDC 
26/2014c). According to this law, prior to mass production 
of the herbal medicines and their distribution among 
the distributors, they are required to be registered. The 
medicines registration will be legally valid for 5 years 
(13). As the data from the interviews indicated, in Iran, 
the Food & Drugs Administration exerts control over the 
procedures of production and distribution of medicinal 
herbs. However, there is no guideline to control either the 
procedure of production and distribution or the vendors of 
the medicinal herbs. This lack of surveillance has created 
numerous problems for the people, including those who 
are inclined to use the medicinal herbs purchased from 
vendors as much confidently and safely as possible.
 Toxicity evaluation is considered as a highly significant 
and critical component in the herbal medicines. One 
of the methods in use for the risk analysis of the herbal 
medicines and their efficacy and toxicity in some 
nations is expressed by therapeutic index defined as 
the ratio LD50/ED50. LD50 reflects the consumption 
dose reported as being toxic in 50% of the population 
while ED50 reflects the consumption dose reported as 
being effective in 50% of the population. Here, the goal 
is to represent the safety of one medicine by focusing 
on the ratio between the efficacy and the amount of 
toxin consumed. Therapeutic index is a major factor 
facilitating the identification of the benefit of the drugs 
(15, 23). Quality control of the chemical compounds used 
in the herbal products is necessary up to the clinical trial 
stage and the reproduction of the clinical trial (30). In 
some cases, wrong identification of the herb has caused 
wrong collection and preparation followed by the wrong 
formulation, leading to certain problems and challenges. 
Quality control is another key factor for the efficacy of 
herbal plants (29). A major advantage of herbal medicines 
is their complexity. The ingredients of herbal medicines 
have multiple functions. Accordingly, the efficacy of herbal 
medicines is higher than conventional drugs (31). Besides 
Table 2. Factors influencing the effects of herbal medicines on the health care quality in nations under study
Factors Number = 27 Percentage (%) References
Reference standards in herbal medicine 3 11.11 (24,27,37)
Regulation of herbal medicinal products 8 30 (13,24,25,28,30,31,43,45)
Toxicity evaluation in herbal products 7 26 (23,25,27,28,30,38,46)
Quality control of herbal medicine 11 40.75 (4,7,9,11,27,31-33,39,42,44)
Efficacy in herbal medicine 9 33.33 (3,4,11,13,25,29,33,39,40)
Adverse effects of herbal medicine 7 26 (7,32,36,38,41,43,46)
Safety in herbal medicine 12 44.45 (3,11,13,29,31,33,38,40-42,45,46)
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that, herbal medicines are usually consumed along with 
other drugs. Therefore, it is essential to be knowledgeable 
about the potential side effects of this combination usage 
and monitor all potential undesirable complications. This 
goal is rapidly attainable by using pharmaco-vigilance 
systems. To control the herbal medicines and analyze 
the reasons for undesirable complications, the national 
pharmaco-vigilance centers (or other equivalent centers) 
must attain the necessary specialized skills. Using standard 
categorization and diagnosis may be desirable for sending 
a report to the Uppsala Monitoring Centre (UMC). Coding 
of the undesirable reactions with herbal medicines must 
be coordinated with the coding system of other drugs. 
Hence, UMC has suggested using WHO-Drug Dictionary 
(WHO-DD). This dictionary has been compiled for 
storing the structural and classified information on the 
names of the herbal products and their ingredients as with 
similar information on other drugs (32). This dictionary 
would increase the efficacy of herbal medicines. 
 Considering the increased demand for the plant-driven 
medicines, it is necessary to provide some guarantees on 
the quality and safety of the herbal medicines. Regarding 
approaches to the applications of herbal medicines from 
the quality control, safety and efficacy perspective, it 
should be argued that traditional usage of these plants 
will require systematic standardization. In India, more 
than 2500 formulations extracted from plants are used 
for producing local and traditional medicines, where over 
1.5 million medical consulters use traditional medicine 
systems for prescribing herbal medicines. Besides that, 
7800 manufacturing units are operating in the field of 
producing the natural health products and traditional 
formulations extracted from the plants (9). After-sales 
supervision is considered as another necessary constituent 
of safety monitoring of herbal plants. Lack of evidence on 
the safety and efficacy of herbal medicines is one of the 
main barriers to the reliable and convenient delivery of 
products to the customers (33). From the interviewees’ 
perspective, to overcome the current barriers, a global 
safety surveillance system should be established so as 
to effectively check the originality and characteristics of 
the herbal products and medicines. In this regard, using 
advanced technologies such as quality control standards 
during the manufacturing and processing of the herbal 
medicines and promoting the evidence-based traditional 
medicine care system would be highly effective. The 
herbal medicines are generally assumed to have no side 
effects. To put it differently, a large number of consumers 
regard herbal medicines as healthier than chemical drugs 
without any possible interactions with other herbal or 
chemical medicines. However, care should be taken that 
the irrational consumption of these medicines may create 
numerous problems that adversely affect patient treatment 
(30,34,35).
Illogical usage of the medicines, lack of qualified 
physicians, unreliable and confusing information, lack 
of sufficient budget, lack of centralized marketing and 
commercialization, and lack of appropriate knowledge 
are all factors that contribute to delaying the global 
advancement of herbal medicines. Lack of protection of 
biodiversity and traditional medicinal plants is a great 
challenge, as well (4). 
When making decisions on the necessity of 
pharmacological and toxicology studies, the documented 
adverse effects of one herb or herb blend, its respective 
types, and herbal combinations should be taken into 
account (10). In Iran, the government is required to 
establish national surveillance systems in different health 
sector levels to monitor and evaluate any possible adverse 
effects. Furthermore, designing such systems must be 
accomplished by consulting with the professionals of 
traditional medicine. 
Conclusion
This review presented a summary of the extant literature 
about the effects of herbal medicine on health care quality 
and those involved in the production and distribution 
of herbal medicinal products. There are numerous 
factors effective on the safety and quality of the herbal 
medicinal products, including the toxicity rate of the 
herbs, environmental pollutions (such as air and soil 
pollution and heavy metals), agricultural activities (such 
as pesticides, fungi, heavy metals, microorganism and 
endotoxins) and processing and production management 
(including the storage, additives, microorganisms and 
endotoxins). Other safety-related issues, including the 
long-term toxicity, dose-dependent toxicity, continuation 
of treatment, herb-drug interactions, and herb-herb 
interactions, should also be evaluated when using herbal 
medicines. The main challenge faced by the majority of 
the herbal medicines consumers is to ensure that they are 
using raw, non-harmful, non-polluted herbal plants with 
stable quality. The increasing incidence of environmental 
pollution such as soils containing heavy metals is one 
inevitable barrier to the global acceptance of herbal 
medicines. To overcome all the existing challenges, various 
considerations should be addressed by the continued 
effort of the governments, training institutions, herbal 
industries as well as consumers. 
Given the results of our review, the following 
recommendations can be proposed for promoting the 
impacts of herbal medicines on healthcare quality and 
dealing with related challenges:
•	 Monitoring the cultivation principles and focusing 
on the quality control infrastructures in the herbal 
medicines industry by respective organizations;
•	 Monitoring the safety principles of the herbal 
medicinal products usage by policymakers in the 
field of traditional medicine and healthcare systems;
•	 Codification of herbal medicine usage standards and 
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monitoring on such standards;
•	 Communication, information and increasing the 
knowledge of the customers regarding the proper use 
of the herbal medicines based on the prescription by 
the traditional medicine practitioners; and
•	 Increasing the knowledge about the side effects 
of herbal medicines and negative effects of self-
medication.
Acknowledgments
We would like to express our deep and sincere gratitude 
to all the authors of the articles for their valuable 
contributions to this review study.
Authors’ contributions
All the authors contributed to data collection and 
preparation of the manuscript. The first draft was prepared 
by APT. All authors read and approved the published 
version of the manuscript.
Conflict of interests 
The authors hereby confirm that there is no conflict of 
interest regarding the publication of this article.
Ethical considerations 
Ethical issues (including plagiarism, data fabrication, 
double publication etc.) have been completely observed 
by the authors.
Funding/Support
This article was obtained from a Ph.D. thesis (No. 
1396.9321563001.IR.IUMS.FMD.REC) at Health 
Information Management and defended at Iran University 
of Medical Sciences.
References
1. Ogirima SAO. Web-based decision support system for 
prescription in herbal medicine. J Emerg Trends Eng Appl 
Sci. 2015;6(7):245-54.
2. 2.Benzie IF, Wachtel-Galor S. Herbal Medicine: 
Biomolecular and Clinical Aspects. 2nd ed. CRC Press; 
2011.
3. Sen S, Chakraborty R, De B. Challenges and opportunities 
in the advancement of herbal medicine: India’s position and 
role in a global context. J Herb Med. 2011;1(3-4):67-75. doi: 
10.1016/j.hermed.2011.11.001.
4. Sen S, Chakraborty R. Revival, modernization and 
integration of Indian traditional herbal medicine in 
clinical practice: Importance, challenges and future. J 
Tradit Complement Med. 2017;7(2):234-44. doi: 10.1016/j.
jtcme.2016.05.006.
5. World Health Organization (WHO). WHO Guidelines 
on Safety Monitoring of Herbal Medicines in 
Pharmacovigilance Systems. WHO; 2004.
6. Mafuva C, Marima-Matarira HT. Towards professionalization 
of traditional medicine in Zimbabwe: a comparative analysis 
to the South African policy on traditional medicine and 
the Indian ayurvedic system. Int J Herb Med. 2014;2(2 Pt 
C):154-61.
7. Mukherjee PK, Bahadur S, Chaudhary SK, Kar A, 
Mukherjee K. Chapter 1 - Quality related safety issue-
evidence-based validation of herbal medicine farm to 
pharma. In: Mukherjee PK, ed. Evidence-Based Validation 
of Herbal Medicine. Boston: Elsevier; 2015. p. 1-28. doi: 
10.1016/b978-0-12-800874-4.00001-5.
8. Motahari Tabari N, Yousefi SS, Heydarirad G, Kardan Soraki 
M, Habibipour P. Exercise from the perspective of Iranian 
traditional medicine. J Evid Based Complementary Altern 
Med. 2017;22(2):344-6. doi: 10.1177/2156587216660396.
9. Bouin AS, Wierer M. Quality standards of the European 
Pharmacopoeia. J Ethnopharmacol. 2014;158 Pt B:454-7. 
doi: 10.1016/j.jep.2014.07.020.
10. World Health Organization (WHO). WHO General 
Guidelines for Methodologies on Research and Evaluation 
of Traditional Medicine. Geneva: WHO; 2000.
11. Govindaraghavan S, Sucher NJ. Quality assessment of 
medicinal herbs and their extracts: criteria and prerequisites 
for consistent safety and efficacy of herbal medicines. 
Epilepsy Behav. 2015;52(Pt B):363-71. doi: 10.1016/j.
yebeh.2015.03.004.
12. Ansani NT, Ciliberto NC, Freedy T. Hospital policies 
regarding herbal medicines. Am J Health Syst Pharm. 
2003;60(4):367-70. doi: 10.1093/ajhp/60.4.367.
13. Carvalho AC, Ramalho LS, Marques RF, Perfeito JP. 
Regulation of herbal medicines in Brazil. J Ethnopharmacol. 
2014;158 Pt B:503-6. doi: 10.1016/j.jep.2014.08.019.
14. Iran Traditional Medicine Association. [updated Dec 2, 
2016; cited 2017 Feb 10]. Available from: https://itma.ir/. 
15. 15.Nessabian S, Gholamhosseni T, Jabalameli F. Comparison 
of Iran’s medicinal plants exporting comparative advantage 
with other exporting countries (case study: Fennel, Badian, 
Anise and Corian). Econ Model. 2013;6(4):75-92.
16. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred 
reporting items for systematic reviews and meta-analyses: 
the PRISMA statement. Ann Intern Med. 2009;151(4):264-
9. doi: 10.7326/0003-4819-151-4-200908180-00135.
17. Pluye P, Robert E, Cargo M, Bartlett G, O’Cathain A, 
Griffiths F, et al. Proposal: A Mixed Methods Appraisal 
Tool for Systematic Mixed Studies Reviews. Montréal: 
McGill University. 2011.
18. Akhlaq A, McKinstry B, Muhammad KB, Sheikh A. 
Barriers and facilitators to health information exchange 
in low- and middle-income country settings: a systematic 
review. Health Policy Plan. 2016;31(9):1310-25. doi: 
10.1093/heapol/czw056.
19. Lucas PJ, Baird J, Arai L, Law C, Roberts HM. Worked 
examples of alternative methods for the synthesis of 
qualitative and quantitative research in systematic reviews. 
BMC Med Res Methodol. 2007;7:4. doi: 10.1186/1471-
2288-7-4.
20. van Panhuis WG, Paul P, Emerson C, Grefenstette J, Wilder 
R, Herbst AJ, et al. A systematic review of barriers to data 
sharing in public health. BMC Public Health. 2014;14:1144. 
doi: 10.1186/1471-2458-14-1144.
21. Salahuddin L, Ismail Z. Classification of antecedents 
towards safety use of health information technology: a 
systematic review. Int J Med Inform. 2015;84(11):877-91. 
Journal of Herbmed Pharmacology, Volume 10, Number 2, April 2021http://www.herbmedpharmacol.com 165
The role of herbal medicines in health care 
doi: 10.1016/j.ijmedinf.2015.07.004.
22. Bonifácio BV, Silva PB, Ramos MA, Negri KM, Bauab TM, 
Chorilli M. Nanotechnology-based drug delivery systems 
and herbal medicines: a review. Int J Nanomedicine. 
2014;9:1-15. doi: 10.2147/ijn.s52634.
23. Kim EJ, Chen Y, Huang JQ, Li KM, Razmovski-Naumovski 
V, Poon J, et al. Evidence-based toxicity evaluation and 
scheduling of Chinese herbal medicines. J Ethnopharmacol. 
2013;146(1):40-61. doi: 10.1016/j.jep.2012.12.027.
24. Zöllner T, Schwarz M. Herbal reference standards: 
applications, definitions and regulatory requirements. Rev 
Bras Farmacogn. 2013;23(1):1-21. doi: 10.1590/s0102-
695x2012005000144.
25. Maegawa H, Nakamura T, Saito K. Regulation of traditional 
herbal medicinal products in Japan. J Ethnopharmacol. 
2014;158 Pt B:511-5. doi: 10.1016/j.jep.2014.07.012.
26. Kroes BH. The legal framework governing the quality of 
(traditional) herbal medicinal products in the European 
Union. J Ethnopharmacol. 2014;158 Pt B:449-53. doi: 
10.1016/j.jep.2014.07.044.
27. Peschel W. The use of community herbal monographs 
to facilitate registrations and authorisations of herbal 
medicinal products in the European Union 2004-2012. 
J Ethnopharmacol. 2014;158 Pt B:471-86. doi: 10.1016/j.
jep.2014.07.015.
28. Claeson P. Requirements on efficacy of herbal medicinal 
products. J Ethnopharmacol. 2014;158 Pt B:463-6. doi: 
10.1016/j.jep.2014.07.017.
29. Wiesner J. Challenges of safety evaluation. J 
Ethnopharmacol. 2014;158 Pt B:467-70. doi: 10.1016/j.
jep.2014.08.013.
30. Wiesner J, Knöss W. Future visions for traditional and 
herbal medicinal products--a global practice for evaluation 
and regulation? J Ethnopharmacol. 2014;158 Pt B:516-8. 
doi: 10.1016/j.jep.2014.08.015.
31. Carmona F, Pereira AMS. Herbal medicines: old and 
new concepts, truths and misunderstandings. Rev Bras 
Farmacogn. 2013;23(2):379-85. doi: 10.1590/s0102-
695x2013005000018.
32. Shetti S, Kumar CD, Sriwastava NK, Sharma IP. 
Pharmacovigilance of herbal medicines: current state and 
future directions. Pharmacogn Mag. 2011;7(25):69-73. doi: 
10.4103/0973-1296.75905.
33. Ung COL, Harnett J, Hu H. Community pharmacist’s 
responsibilities with regards to traditional medicine/
complementary medicine products: a systematic literature 
review. Res Social Adm Pharm. 2017;13(4):686-716. doi: 
10.1016/j.sapharm.2016.08.001.
34. Owens C, Baergen R, Puckett D. Online sources of herbal 
product information. Am J Med. 2014;127(2):109-15. doi: 
10.1016/j.amjmed.2013.09.016.
35. Wang JF, Zhou H, Han LY, Chen X, Chen YZ, Cao ZW. 
Traditional Chinese medicine information database. 
Clin Pharmacol Ther. 2005;78(1):92-3. doi: 10.1016/j.
clpt.2005.03.010.
36. Girard L, Kutt A, Necyk C, Jasser S, Law B, Filipelli A, et al. 
P05.32. A tool for rapid identification of potential herbal 
medicine-drug interactions 2011 update: a review. BMC 
Complement Altern Med. 2012;12(Suppl 1):P392. doi: 
10.1186/1472-6882-12-S1-P392.
37. Mustaffa S, Ishak RZ, Lee C, Lim S, Sintoh M, Selan NE. 
Herbal medicine knowledge base system. Agricultural 
Ontology Service (AOS) Workshop; 2012.
38. Yang HC, Iqbal U, Nguyen PA, Lin SH, Huang CW, 
Jian WS, et al. An automated technique to identify 
potential inappropriate traditional Chinese medicine 
(TCM) prescriptions. Pharmacoepidemiol Drug Saf. 
2016;25(4):422-30. doi: 10.1002/pds.3976.
39. Mekuria AB, Erku DA, Gebresillassie BM, Birru EM, 
Tizazu B, Ahmedin A. Prevalence and associated factors of 
herbal medicine use among pregnant women on antenatal 
care follow-up at University of Gondar referral and 
teaching hospital, Ethiopia: a cross-sectional study. BMC 
Complement Altern Med. 2017;17(1):86. doi: 10.1186/
s12906-017-1608-4.
40. Zhang YQ, Mao X, Guo QY, Lin N, Li S. Network 
pharmacology-based approaches capture essence of 
Chinese herbal medicines. Chin Herb Med. 2016;8(2):107-
16. doi: 10.1016/s1674-6384(16)60018-7.
41. Huang C, Zheng C, Li Y, Wang Y, Lu A, Yang L. Systems 
pharmacology in drug discovery and therapeutic insight for 
herbal medicines. Brief Bioinform. 2014;15(5):710-33. doi: 
10.1093/bib/bbt035.
42. Liu SH, Chuang WC, Lam W, Jiang Z, Cheng YC. Safety 
surveillance of traditional Chinese medicine: current and 
future. Drug Saf. 2015;38(2):117-28. doi: 10.1007/s40264-
014-0250-z.
43. Snow J. Context effects in Western herbal medicine: 
fundamental to effectiveness? Explore (NY). 2016;12(1):55-
62. doi: 10.1016/j.explore.2015.10.004.
44. Evans S. Changing the knowledge base in Western herbal 
medicine. Soc Sci Med. 2008;67(12):2098-106. doi: 
10.1016/j.socscimed.2008.09.046.
45. Smith A, Jogalekar S, Gibson A. Regulation of natural 
health products in Canada. J Ethnopharmacol. 2014;158 Pt 
B:507-10. doi: 10.1016/j.jep.2014.06.037.
46. Niemeyer K, Bell IR, Koithan M. Traditional knowledge 
of Western herbal medicine and complex systems 
science. J Herb Med. 2013;3(3):112-9. doi: 10.1016/j.
hermed.2013.03.001.
